Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 28-12-2015 |
Asset Class: Equity |
Benchmark: NIFTY Pharma TRI |
TER: 2.19% As on (28-02-2025) |
Status: Open Ended Schemes |
Minimum Investment: 5,000 |
Minimum Topup: 1,000 |
Total Assets: 1,103.99 Cr As on 28-02-2025(Source:AMFI) |
Turn over: 0.7% |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Standard Deviation | |
Sharpe Ratio | |
Alpha | |
Beta | |
Yield to Maturity | |
Average Maturity |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | 28-12-2015 | 14.26 | 35.08 | 18.96 | 27.67 | - |
HDFC Pharma and Healthcare Fund - Growth Option | 04-10-2023 | 29.56 | - | - | - | - |
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth | 06-02-2024 | 27.97 | - | - | - | - |
UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | 20.07 | 37.55 | 19.78 | 28.47 | 10.7 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 14-07-1999 | 19.98 | 38.83 | 23.26 | 30.44 | 11.66 |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
29.09%
Others
1.95%
Large Cap
35.93%
Mid Cap
33.03%